Skip to main content
. 2021 Jul 7:NEJMoa2107715. doi: 10.1056/NEJMoa2107715

Table 3. Effectiveness of CoronaVac Vaccine in Preventing Covid-19 Outcomes among Cohort Participants 60 Years of Age or Older, According to Immunization Status.

Outcome and Immunization Status Subgroup Cohort Persons with Covid-19 Vaccine Effectiveness (95% CI)
No. of
Person-Days
No. of
Persons
Incidence
Rate
Analysis
Adjusted for
Sex and Age
Analysis
Adjusted for
All Covariates*
Stratified
Analysis
no. of events/
1000 person-days
percent
Covid-19
Unvaccinated 75,707,905 15,597 0.2060
Partially immunized 35,675,604 8,333 0.2336 3.9
(0.9–6.8)
9.7
(6.9–12.4)
12.7
(9.8–15.5)
Fully immunized 66,563,272 7,510 0.1128 63.4
(62.0–64.6)
66.6
(65.4–67.8)
67.2
(66.0–68.4)
Hospitalization
Unvaccinated 76,047,640 5,304 0.0697
Partially immunized 35,961,593 2,168 0.0603 29.2
(25.1–33.1)
35.0
(31.3–38.6)
38.6
(34.8–42.2)
Fully immunized 66,986,859 1,344 0.0201 83.4
(82.2–84.5)
85.3
(84.3–86.3)
85.4
(84.3–86.4)
Admission to ICU
Unvaccinated 76,194,648 1,811 0.0238
Partially immunized 36,062,081 672 0.0186 38.2
(31.9–44.0)
44.5
(38.7–49.7)
47.0
(41.2–52.2)
Fully immunized 67,051,769 331 0.0049 87.5
(85.7–89.0)
89.2
(87.6–90.6)
89.3
(87.8–90.7)
Confirmed death
Unvaccinated 76,169,386 1,999 0.0262
Partially immunized 36,053,806 768 0.0213 39.7
(33.8–45.1)
45.8
(40.4–50.7)
46.1
(40.5–51.2)
Fully immunized 67,045,620 402 0.0060 84.4
(82.3–86.2)
86.5
(84.6–88.1)
86.8
(85.0–88.4)
*

The analysis was adjusted for age, sex, region of residence, income, nationality, and whether the patient had underlying conditions that have been associated with severe Covid-19.

A stratified version of the extended Cox proportional-hazards model was fit to test the robustness of the estimates to model assumptions, with stratification according to sex, age, coexisting conditions, nationality, and income.

HHS Vulnerability Disclosure